Atlas Trials

MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma

Clinical trial NCT01748721 · COMPLETED

Trial details

NCT number
NCT01748721
Sponsor
Morphotek
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell LymphomaChildhood Burkitt LymphomaChildhood Diffuse Large Cell LymphomaChildhood Immunoblastic Large Cell LymphomaChildhood Nasal Type Extranodal NK/T-cell LymphomaCutaneous B-cell Non-Hodgkin LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueHepatosplenic T-cell LymphomaIntraocular LymphomaNodal Marginal Zone B-cell Lymphoma
Start date
2013-11-01
Primary completion
2015-05-01
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.